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Abstract:
Background: Review of the literature suggests that anxiety is more common among patients
with asthma than among the general population, yet it does not appear to be given the attention
it deserves as part of the overall management of asthma. The aim of this study was to
investigate the relationship between anxiety and asthma management, in terms of Global
Initiative for Asthma steps, lung function and medication.
Methods: A total of 201 consecutive patients with respiratory physician-diagnosed asthma were
recruited from an adult outpatient asthma clinic. Participants underwent a sociodemographic
review, and a medical interview which included a detailed drug history. Forced expiratory
volume in 1 second (FEV1) and peak expiratory flow (PEF) values were recorded using a Micro
Medical portable spirometer. The level of anxiety was assessed using the Beck Anxiety
Inventory (BAI).
Results: A total of 51.5% of participants registered clinically significant levels of anxiety. Of
these only 21% had already been diagnosed and were receiving treatment. Females reported
significantly higher BAI scores than males (p< 0.01). More females (66.3%) registered clinically
significant levels of anxiety as compared with males (33.7%) (p< 0.05). There was a positive
correlation between the BAI score and the prescribed dose of inhaled glucocorticoids
(rs¼ 0.150, p< 0.05) and between anxiety and GINA treatment step (rs¼ 0.139, p< 0.05). There
was also a positive correlation between anxiety and the number of medicines taken by patients
(rs¼ 0.259, p< 0.001).
Conclusions: Physicians treating patients with asthma should be sensitised to the association
between asthma and anxiety, and should also consider assessing patients for the possibility of
anxiety disorders as part of asthma management plans.
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Introduction
The focus of treatment decisions in asthma
should be based on control of the condition
[GINA, 2008]. The current trend in asthma man-
agement is therefore aimed at addressing the
‘unmet needs in asthma’ which arise from factors
related to poor disease control [Rabe et al. 2004].
The overall aim is to achieve better control of
asthma with patients leading as normal a life as
possible. Asthma management guidelines give a
clear definition of control: this is not limited to
optimising lung function but incorporates symp-
tom control, a fulfilling lifestyle, proper use of
rescue/reliever medication, and reduction in the
number and severity of exacerbations. Increasing
emphasis is being placed on the patient being a
full partner in the management decisions to
achieve control [GINA, 2008; NAEEP, 2007].
This can only be achieved through a strong doc-
torpatient relationship, and one which allows
for enough time to make a holistic assessment of
patients’ needs, addressing any underling pro-
blems and concerns. Any psychiatric symptoms,
psychological disturbance and perception of
asthma should also be assessed, as these factors
could contribute significantly to diminished con-
trol of asthma [Bosley et al. 1996].
The relationship between asthma and anxiety has
long been established [Smoller and Otto, 1998;
Yellowlees and Kalucy, 1990] and various studies
have established that anxiety is more common in
persons with asthma than in the general popula-
tion. Persons with asthma have been found to be
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twice as likely to report frequent mental distress
(FMD) as compared with those without asthma.
Asthmatics with FMD were more likely to report
frequent anxiety symptoms [Strine et al. 2004].
Goodwin et al. [2004] reported elevated rates of
depressive and anxiety disorders among young
adults with asthma as compared with their coun-
terparts without asthma in the community. A
population-based study of adolescents with
asthma found that those with an anxiety or
depressive disorder reported significantly more
asthma symptoms than those not presenting
with these disorders [Richardson et al. 2006].
Studies have also found elevated rates of asthma
amongst patients with anxiety disorders. Higher
rates of asthma were found among adolescent
psychiatric inpatients with post-traumatic stress
disorder (PTSD) [Koltek et al. 1998] and similar
findings were reported in primary care patients
[Weisberg et al. 2002]. The association between
asthma and anxiety appears to exist indepen-
dently of the degree of severity of asthma
[Valenca et al. 2006; Brinke et al. 2001].
The possibility of anxiety as a risk factor for
developing asthma was examined by Jonas et al.
[1999] and it was found that the relative risks of
developing asthma were increased significantly in
nonsmokers with high and intermediate levels of
anxiety symptoms. The presence of anxiety in
patients with asthma has been associated with
suboptimal asthma-related quality of life and is
possibly linked to decreased adherence to therapy
[Lavoie et al. 2006; Cluley and Cochrane, 2001].
While the link between asthma and anxiety is
evident, the causal direction between anxiety
and poor disease management and control
remains unclear. It may either be a consequence
of, or a contributor to the condition. A Swiss
community-based, prospective longitudinal
study investigated whether active asthma pre-
dicted subsequent panic disorder and whether
tendency to panic predicted active asthma. The
results indicate both that active asthma predicted
subsequent panic disorder and vice-versa. This
effect was more pronounced among women and
persons under the age of 30 years. However, the
major limitation of this study was that the diag-
nosis of asthma was self-reported [Hasler et al.
2005]. The aim of this study is to investigate
the relationships between patient anxiety and
asthma management, in terms of GINA step,
lung function and medication.
Methods
Study subjects
A consecutive series of outpatients with respira-
tory physician-confirmed asthma was recruited
from the adult asthma clinic at St Luke’s
Hospital, Malta over a 3-month period. Patients
were eligible for inclusion if they had a primary
diagnosis of asthma and were receiving inhaled
glucocorticoid therapy for a duration of 12
months or more. A total of 215 patients pre-
sented at the asthma clinic, all of whom were
screened for inclusion in the study. A total of
14 patients did not satisfy the criteria for inclu-
sion in the study (10 patients had been on
inhaled glucocorticoid therapy for less than a
year, one patient was not on inhaled glucocorti-
coids and three patients refused to participate).
Informed consent was obtained from all patients
and ethical approval for the study was obtained
from the Research Ethics Committee of the
University of Malta.
Study design
Eligible participants underwent a medical inter-
view to document sociodemographic characteris-
tics, medical history and a detailed drug history
covering their asthma medication as well as any
other medication they were concurrently taking.
All information was verified by cross-referencing
to the patients’ medical files. Information regard-
ing prescribed asthma medication was used to
classify patients according to one of the five
asthma treatment steps as defined by GINA.
Patients also underwent spirometry testing in
line with European Respiratory Society guide-
lines [European Respiratory Society, 1993].
Forced expiratory volume in one second (FEV1)
and peak expiratory flow (PEF) were recorded
using a Micro Medical portable spirometer.
Assessment tool
The level of anxiety was assessed using the Beck
Anxiety Inventory (BAI). The BAI consists of 21
descriptive statements of anxiety symptoms
which are rated on a four-point scale ranging
from 0 to 3. The maximum score is 63 points.
Total scores from 0 to 7 are considered to reflect
a minimal level of anxiety, scores of 815 indicate
mild anxiety, scores of 1625 reflect moderate
anxiety and scores of 2663 indicate severe anxi-
ety. A clinically significant level of anxiety was
defined by a score of 16 on the BAI [Beck
and Steer, 1993].
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Data analysis
The data were analysed using SPSS version 15.
Spearman rank order correlation coefficient was
used to determine relationships between anxiety
and age, prescribed dose of inhaled glucocorti-
coid, GINA step, FEV1, PEF and the number
of different types of medicines patients were
taking. Spearman rank order correlation coeffi-
cient was used to determine the relationship
between lung function parameters of FEV1 and
PEF with prescribed dose of inhaled glucocorti-
coid and GINA step. The MannWhitney test
was used to determine relationships between
FEV1, gender and anxiety. The KruskalWallis
test was used to determine relationships between
anxiety and comorbidities. For the purpose of
analysing GINA step and anxiety, steps 4 and 5
were combined. A p-value of <0.05 was consid-
ered significant.
Results
The characteristics of the study sample are sum-
marised in Table 1. A total of 58% had percent-
age predicted FEV1 of 80%, 23% had a
percentage predicted FEV1 between 60% and
79%, and 19% had a percentage predicted
FEV1 of <60%. Females, had a higher mean per-
centage predicted FEV1 (females: 85±2.63,
males: 77.8±2.4, p< 0.05). The majority of
patients were being treated at GINA steps 4
and 5 with 57.7% receiving a high (>1000mg
beclomethasone or equivalent) daily dose of
inhaled glucocorticoids. A total of 45.7% of
patients studied, had chronic comorbid condi-
tions. There were predominantly cardiovascular
problems (29.4%), anxiety/depression (13.4%),
other respiratory disorders (mainly rhinitis),
(10%) and diabetes mellitus (7%).
The mean BAI score was 17.7±0.8 (SEM), with
51.5% registering clinically significant levels of
anxiety (BAI 16) as presented in Table 2. Of
these only 21% had their anxiety formally diag-
nosed and were receiving treatment for such.
Females reported significantly higher BAI
scores than males (19.6±1.06 versus 15.1±1.2,
p< 0.01). More females registered clinically sig-
nificant levels of anxiety as compared with males
(66.3% versus 33.7%, p< 0.05). There was a pos-
itive correlation between the BAI score and the
prescribed dose of inhaled glucocorticoids
(rs¼ 0.150, p<0.05). A positive correlation was
also established between anxiety and GINA treat-
ment step (rs¼ 0.139, p< 0.05). Further analysis
revealed a positive correlation between anxiety
and the number of medicines taken by patients
(rs¼ 0.259, p< 0.001). When analysed indepen-
dently both genders showed a positive correlation
between the number of medicines being taken
and anxiety (males: rs¼0.267, p< 0.05, females:
rs¼ 0.260, p< 0.01).
Negative correlations were established between
percentage predicted FEV1 and dose of pre-
scribed inhaled glucocorticoid (rs¼0.352,
p< 0.01), PEF and dose of prescribed inhaled
glucocorticoid (rs¼0.267, p< 0.01), percent-
age predicted FEV1 and GINA step (rs ¼
0.397, p< 0.01), and PEF and GINA step
(rs¼0.296, p< 0.01). There was no association
between the objective asthma-related variables of
percentage predicted FEV1 and PEF and anxiety.
Age, or the number of diagnosed comorbid con-
ditions, were not significantly associated with
anxiety.
Discussion
The results of the present study are consistent
with and extend previous findings related to
the association between asthma and anxiety.
Table 1. Characteristics of patients.
Characteristic
Total 201
Females 118 (58.7%)
Age mean (years) 48.9±1.25
Age range (years) 1783
FEV1 (mean % predicted) 82.01±1.67
PEF (mean % predicted) 77.53±1.79
Patient treatment
(GINA guidelines)
Step 2 57 (28.4%)
Step 3 26 (12.9%)
Step 4 108 (53.7%)
Step 5 10 (5%)
Prescribed medicines mean 3.5±0.13
Range 19
Patients receiving treatment
for anxiety
27 (13.4%)
Mean values are given±SEM
Table 2. Severity of anxiety using the Beck Anxiety Inventory (BAI).
Anxiety level Male Female Total
(BAI Score)
No % No % No %
Minimal (07) 19 23.0 20 16.9 39 19.4
Mild (815) 29 34.9 29 24.6 58 28.9
Moderate (1625) 21 25.3 33 28.0 54 26.6
Severe (2663) 14 16.8 36 30.5 50 24.9
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Our data confirm a high prevalence of anxiety
among patients with asthma (51.5%). These
findings fall in the upper end of the prevalence
spectrum of anxiety in asthma as reported in the
literature [Katon et al. 2004] and are in line with
a similar study which reported a 52.3% preva-
lence of anxiety carried out in an outpatient
asthma unit setting in Brazil [Nasciemento et al.
2002]. The high level of anxiety documented in
the present study did not have any impact on
lung function, as there was no correlation
between the objective measures of FEV1 or
PEF with anxiety; this finding is also supported
by other studies [Krommydas et al. 2004;
Rimingtom et al. 2001]. It has been suggested
that the association between asthma and anxiety
may be due to the central role of respiratory fac-
tors in anxiety disorders. Anxiety itself may lead
to hyperventilation, irrespective of the degree of
objective pulmonary impairment, and in the
presence of some form of airways obstruction, it
may result in increased breathlessness [Carr,
1998]. As in the general population, the majority
of the patients with clinically significant anxiety
(79%) were undiagnosed and untreated, a find-
ing also supported by other studies [Valenca et al.
2006; Goodwin, 2003]. Various barriers have
been cited with regards to the diagnosis and treat-
ment of anxiety, such as the stigma perceived by
patients, who would tend to exaggerate their
somatic complaints, to health care professionals
lacking interest and time to make the appropriate
diagnosis [Kunik et al. 2005]. An additional pos-
sibility is the limited availability of integrated
mental health services at community level
[Rutz, 2002]. Furthermore, studies related to
physicianpatient interaction in asthma manage-
ment have shown that patients’ concerns may not
be sufficiently addressed due to lack of time and
poor communication [Canonica et al. 2007;
Moffat et al. 2006].
Women reported significantly higher levels of anx-
iety than males (19.6 versus 15.1) despite register-
ing significantly higher mean levels of percentage
predicted FEV1 (85% versus 77.8%). It is well
established that women are more likely to develop
anxiety disorders then men [Pigott, 1999] and the
BAI manual [1993] also indicates that the BAI
score for women may be an average of four
points higher than for men. This trend has also
been reflected in other studies related to anxiety
and respiratory disease [Moussas et al. 2008]. In a
study of postmenopausal women aged 50 years
and over, Smoller et al. [2003] reported that
women with a history of asthma were more
likely to report full-blown panic attacks. This
relates well with the findings in the present
study whereby 66.7% of women who reported
clinically significant anxiety were aged 50 years
and over. The increased levels of anxiety in
women notwithstanding better percentage pre-
dicted FEV1 is supported by Carr et al.’s [1996]
work, which also found a positive association with
lung function. There are, however, other studies
which have found no gender differences in the
levels of anxiety between males and females
[Deshmukh et al. 2008].
Higher levels of anxiety were positively associated
with high doses of inhaled glucocorticoids and
consequently management at higher GINA
steps. Considering that the majority of the
study sample (58%) had a predicted FEV1 of
over 80% and 57.7% of population were receiv-
ing high doses of inhaled glucocorticoids, it is
pertinent to question the basis for the sustained
prescription of high doses of inhaled glucocorti-
coids, especially since at each patient visit to
asthma clinic, lung function tests are performed.
Our data did, however, produce a negative corre-
lation between lung function (FEV1, PEF) and
prescribed dose of inhaled glucocorticoids as
well as GINA step, indicating the lower the
lung function the higher the treatment step.
This result also provides validity to our popula-
tion reflecting the study by Rimington et al.
[2001]. Other studies failed to document a rela-
tionship between FEV1, PEF, FVC and physi-
cians’ prescribing decisions [Hyland et al. 1993].
It is possible that prescribing decisions are mostly
based on patients’ reported symptoms without
giving sufficient weight to lung function values.
It is also possible, that physicians could treat a
psychological problem as a medical problem
and overprescribe inhaled glucocrticoids instead
of identifying and treating the underlying anxiety
[Dirks et al. 1979]. An additional factor worth
considering is that medications used to control
asthma (i.e. inhaled glucocorticoids, adrenore-
ceptor agonists and theophylline) have all been
implicated in provoking anxiety. In our sample,
all patients had been on inhaled glucocorticoids
for over a year, 5% were on long-term low-dose
oral steroids, 11.4% had taken a rescue course
within the preceding 3 months, 10.4% were
taking steroids intranasally, 10% were addition-
ally taking long-acting beta adrenergic agonists
and 9.4% were taking theophylline. All the
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patients in our study were taking inhaled salbu-
tamol on an ‘as required’ basis. All these medica-
tions could have contributed to the high anxiety
levels recorded.
Our data revealed a relationship between the
number of different medications taken by
the patient and anxiety levels. The higher the
number of medications, the higher the anxiety
level recorded; this fact could also in itself be
an additional contributing factor to the high anx-
iety levels. Patients suffering from respiratory and
cardiovascular disease are particularly prone to
polypharmacy [Bjerrum et al.1998] which in
turn is likely to lead to inappropriate use of med-
icines. The frequency of inappropriate medica-
tion use rises with the number of medicines
being taken [Steinmen et al. 2006] and it follows
that in encounters with patients, appropriate
multifaceted, multidisciplinary interventions
should be aimed at optimising use of
medications.
There are a number of limitations to the present
study. The group of patients studied attended a
respiratory specialist-run outpatient asthma
clinic. Patients attending this clinic are perceived
to fall in the moderate-to-severe spectrum of
severity and do not mirror the general popula-
tion. The level of anxiety was self-reported and
was not validated by a professional structured
diagnostic assessment. The study did not record
data relating to patients’ symptoms, which could
have given a more comprehensive picture of the
study population. The present study was an
observational, uncontrolled, cross-sectional
study and therefore cannot determine if the
observed associations are causal or not.
Physicians treating patients with asthma should
be sensitised to the association between asthma
and anxiety and should also consider assessing
the patient for possibility of anxiety disorders.
A systematic evaluation for possible comorbid
anxiety disorders should be a part of asthma
management [Boulet, 2009]. While the diagnosis
of anxiety disorders in patients with asthma may
be challenging, it may at times be more appropri-
ate to treat the anxiety state rather than step up
the medication. This approach could have a ster-
oid-sparing effect, achieving control at the lowest
possible dose. Judicious use of anxiolytic medica-
tion is necessary due to negative effect of certain
medications within this class (e.g. benzodiaze-
pines) on breathing. The use of alternative
approaches to the management of anxiety in
patients such as cognitive behaviour therapy
[Deshmukh et al. 2007] may also help to achieve
a positive outcome while avoiding the additional
use of medicines.
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